drugset
drugset / Trial / NCT00598832

Clinical Study to Test the Efficacy and Safety of Adapalene, 0.1%

NCT00598832 ↗

Phase 3 Completed 1075 enrolled Galderma R&D
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to determine whether Adapalene, 0.1% is safe and effective in the treatment of Acne Vulgaris.

Timeline

Start
2007-11
Primary completion
2008-10
Completion
2008-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Adapalene Other / unclassified 0.1 % Topical

Indications

acne